Myelodysplastic Syndrome

Showing NaN - NaN of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome
  • ASP7517
  • Duarte, California
  • +15 more
Jan 19, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • haplo-identical cells (donor)
  • umbilical cord blood unit (CBU)
  • New York, New York
    Weill Cornell Medical College
Dec 14, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte, New York, Houston (BTX-A51)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +2 more
Sep 8, 2022

Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Geriatric assessment (GA) pre-transplant
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 24, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • ATIR101
    • +3 more
    • Duarte, California
    • +41 more
    Apr 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • SY-1425 (tamibarotene)
    • +2 more
    • Hartford, Connecticut
    • +25 more
    May 4, 2022

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • FT-2102 (olutasidenib)
    • +2 more
    • Los Angeles, California
    • +59 more
    Mar 2, 2022

    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

    Active, not recruiting
    • Anemia
    • +3 more
    • Epoetin Alfa
    • +2 more
    • Birmingham, Alabama
    • +512 more
    Mar 1, 2022

    Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

    Active, not recruiting
    • Myelodysplastic Syndrome
    • Revlimid (Lenalidomide)
    • New York, New York
      Columbia University Medical Center
    Jan 12, 2022

    Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

    Active, not recruiting
    • Acute Leukemia
    • +3 more
    • cytogenetic analysis
    • La Jolla, California
    • +136 more
    Aug 16, 2021

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • New York, New York
      Columbia University Medical Center
    Aug 4, 2021

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

    Completed
    • Myelodysplastic Syndrome
    • +2 more
    • Gilbert, Arizona
    • +12 more
    Jun 15, 2021

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

    Completed
    • Acute Lymphoblastic Leukemia
    • +3 more
    • total body irradiation
    • +7 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 17, 2021